Literature DB >> 6313005

cis-Platinum: subcellular distribution and binding to cytosolic ligands.

R P Sharma, I R Edwards.   

Abstract

In the present experiments the tissue uptake and subcellular distribution of Pt were measured in the liver and kidney of rats injected intraperitonially with 5 mg cis-diamminedichloroplatinum (cis-DPP)/kg. The binding of Pt to cytosolic ligands was also investigated. In both the liver and kidney Pt concentration was maximal within 24 hr following cis-DDP injection. Thereafter the clearance was bimodal with a rapid phase of about 48 hr (with 60-70% clearance) followed by a slow incomplete phase. In the kidney relatively high concentrations of Pt were measured in the microsomal, lysosomal and mitochondrial fractions. But in the liver the higher levels were found in the microsomal and nuclear fractions. On average 62% (kidney) and 89% (liver) of the cellular Pt were localized in the cytosol. At 24 hr following cis-DDP injection, about 52% of cytosolic Pt was present as low molecular weight species (molecular weight less than 1000) and the remainder as protein-bound. About 25% was bound to a metallothionein-like protein in the liver as well as the kidneys. It is suggested that the high localization of cellular Pt in the cytosol and the presence of a high proportion as non-protein bound species may be important factors in relation to the therapeutic as well as the toxic effects of cis-DDP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313005     DOI: 10.1016/0006-2952(83)90073-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Preferential energy- and potential-dependent accumulation of cisplatin-gutathione complexes in human cancer cell lines (GLC4 and K562): A likely role of mitochondria.

Authors:  Simplice Dzamitika; Milena Salerno; Elene Pereira-Maia; Laurence Le Moyec; Arlette Garnier-Suillerot
Journal:  J Bioenerg Biomembr       Date:  2006-05-27       Impact factor: 2.945

2.  Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.

Authors:  P Farnworth; B Hillcoat; I Roos
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy.

Authors:  Jennifer J Sudimack; Dianne Adams; Joan Rotaru; Supriya Shukla; Junhua Yan; Masaru Sekido; Rolf F Barth; Werner Tjarks; Robert J Lee
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

4.  Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.

Authors:  R Parti; W Wolf
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs.

Authors:  Justin C Jagodinsky; Agnieszka Sulima; Yiqi Cao; Joanna E Poprawski; Burchelle N Blackman; John R Lloyd; Rolf E Swenson; Michael M Gottesman; Matthew D Hall
Journal:  J Biol Inorg Chem       Date:  2015-09-01       Impact factor: 3.358

6.  Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells.

Authors:  P A Andrews; M P Murphy; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  The effect of cisplatin on renal ATPase activity in vivo and in vitro.

Authors:  J Uozumi; C L Litterst
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics.

Authors:  Cynthia S Lancaster; Jason A Sprowl; Aisha L Walker; Shuiying Hu; Alice A Gibson; Alex Sparreboom
Journal:  Mol Cancer Ther       Date:  2013-06-11       Impact factor: 6.261

9.  Mitochondrial ClpP activity is required for cisplatin resistance in human cells.

Authors:  Yang Zhang; Michael R Maurizi
Journal:  Biochim Biophys Acta       Date:  2015-12-07

10.  DNA-protein cross-linking in L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).

Authors:  R Olinski; R C Briggs
Journal:  Mol Biol Rep       Date:  1991-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.